Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1990 1
1996 1
1997 1
1998 1
2000 1
2005 5
2006 1
2007 2
2011 1
2012 2
2013 1
2014 1
2015 1
2016 1
2017 2
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial.
Dearnaley D, Syndikus I, Mossop H, Khoo V, Birtle A, Bloomfield D, Graham J, Kirkbride P, Logue J, Malik Z, Money-Kyrle J, O'Sullivan JM, Panades M, Parker C, Patterson H, Scrase C, Staffurth J, Stockdale A, Tremlett J, Bidmead M, Mayles H, Naismith O, South C, Gao A, Cruickshank C, Hassan S, Pugh J, Griffin C, Hall E; CHHiP Investigators. Dearnaley D, et al. Among authors: bidmead m. Lancet Oncol. 2016 Aug;17(8):1047-1060. doi: 10.1016/S1470-2045(16)30102-4. Epub 2016 Jun 20. Lancet Oncol. 2016. PMID: 27339115 Free PMC article. Clinical Trial.
Radiotherapy planning techniques for thyroid cancer.
Harmer C, Bidmead M, Shepherd S, Sharpe A, Vini L. Harmer C, et al. Among authors: bidmead m. Br J Radiol. 1998 Oct;71(850):1069-75. doi: 10.1259/bjr.71.850.10211068. Br J Radiol. 1998. PMID: 10211068 Review.
Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer.
Naismith O, Mayles H, Bidmead M, Clark CH, Gulliford S, Hassan S, Khoo V, Roberts K, South C, Hall E, Dearnaley D; CHHiP Investigators. Naismith O, et al. Among authors: bidmead m. Clin Oncol (R Coll Radiol). 2019 Sep;31(9):611-620. doi: 10.1016/j.clon.2019.05.009. Epub 2019 Jun 11. Clin Oncol (R Coll Radiol). 2019. PMID: 31201110 Clinical Trial.
Three-dimensional planning and conformal radiotherapy.
Harmer C, Bidmead M. Harmer C, et al. Among authors: bidmead m. Cancer Treat Res. 1997;91:129-41. doi: 10.1007/978-1-4615-6121-7_9. Cancer Treat Res. 1997. PMID: 9286493 Review. No abstract available.
Treatment accuracy of fractionated stereotactic radiotherapy.
Kumar S, Burke K, Nalder C, Jarrett P, Mubata C, A'hern R, Humphreys M, Bidmead M, Brada M. Kumar S, et al. Among authors: bidmead m. Radiother Oncol. 2005 Jan;74(1):53-9. doi: 10.1016/j.radonc.2004.06.008. Radiother Oncol. 2005. PMID: 15683670 Clinical Trial.
Final long-term results of a phase I/II study of dose-escalated intensity-modulated radiotherapy for locally advanced laryngo-hypopharyngeal cancers.
Gujral DM, Miah AB, Bodla S, Richards TM, Welsh L, Schick U, Powell CJ, Clark CH, Bidmead MA, Grove L, Guerrero-Urbano T, Bhide SA, Newbold KL, Harrington KJ, Nutting CM. Gujral DM, et al. Among authors: bidmead ma. Oral Oncol. 2014 Nov;50(11):1089-97. doi: 10.1016/j.oraloncology.2014.07.018. Epub 2014 Sep 6. Oral Oncol. 2014. PMID: 25200524 Clinical Trial.
23 results